Genmab Announces that Janssen has Submitted a Biologics License Application to U.S. FDA for Amivantamab in Non-small Cell Lung Cancer

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing